Using the industry peer median P/E multiple (trailing + forward), Revvity, Inc. (RVTY) has a fair value of $61.25 based on 2 comparable companies in the Medical - Diagnostics & Research industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing P/E | Forward P/E | |
|---|---|---|---|
| Revvity, Inc.RVTY | 9,907 | 42.1x | 16.2x |
| Align Technology, Inc.ALGN | 12,758 | 31.5x | 17.4x |
| Solventum CorporationSOLV | 11,227 | 7.3x | 10.7x |
| Industry Median | 19.4x | 14.1x | |
| (*) Profit after tax | 242 | 611 | |
| Equity Value | 4,684 | 9,184 | |
| (/) Outstanding shares | 113 | 113 | |
| Fair Price | $41 | $81 | |
This P/E relative valuation uses the industry peer median Price-to-Earnings ratio to estimate fair value. Both trailing (last 12 months) and forward (next fiscal year analyst estimates) P/E multiples are computed independently.
The industry median trailing P/E is applied to the company's TTM net income, and the forward P/E to analyst-estimated net income. Each produces an equity value divided by shares outstanding to yield a fair price per share. The selected fair value is the average of the trailing and forward legs.